Abstract
Pituitary adenomas (PAs) are common, benign intracranial tumors that are usually effectively controlled with surgery, pharmacotherapy or radiotherapy. Some PAs against which conventional treatment is ineffective are great clinical challenges at present. Autophagy is a widespread physiological process in cells. Through autophagy, cells can degrade damaged or redundant proteins and organelles and achieve the recycling of intracellular substances to maintain the homeostasis of the intracellular environment. An increasing number of studies have demonstrated the importance of autophagy in tumor therapy. Both radiotherapy and chemotherapy can induce autophagy, which plays different roles in the course of therapy. In recent years, there has been growing interest in the role of autophagy during the treatment of PAs. This chapter reviews the recent progress of research on autophagy in PA and the autophagic mechanisms in the treatment of PA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Azzawi H, Yacqub-Usman K, Richardson A et al (2011) Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis. Endocrinology 152(2):364–373
Almalki MH, Aljoaib NN, Alotaibi MJ et al (2017) Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review. Hormones (Athens) 16(2):139–149
Amaravadi RK, Lippincott-Schwartz J, Yin XM et al (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17(4):654–666
An JJ, Cho SR, Jeong DW et al (2003) Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells. Mol Cell Endocrinol 206(1–2):49–62
Aoki H, Kondo Y, Aldape K et al (2008) Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy 4(4):467–475
Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63(1):182–217
Bernabe A, Gomez MA, Seva J et al (2001) Light and ultrastructural immunocytochemical study of prolactin cells in ovine adenohypophysis. Influence of lactation and weaning. Cells Tissues Organs 168(4):264–271
Chaachouay H, Ohneseit P, Toulany M et al (2011) Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother Oncol 99(3):287–292
Chatzellis E, Alexandraki KI, Androulakis II et al (2015) Aggressive pituitary tumors. Neuroendocrinology 101(2):87–104
Chiu HW, Chen YA, Ho SY et al (2012) Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and -independent human prostate cancer cells. PLoS ONE 7(2):e31579
Chiu HW, Yeh YL, Wang YC et al (2013) Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo. PLoS ONE 8(10):e76340
Chiu HW, Lin SW, Lin LC et al (2015) Synergistic antitumor effects of radiation and proteasome inhibitor treatment in pancreatic cancer through the induction of autophagy and the downregulation of TRAF6. Cancer Lett 365(2):229–239
Colao A, Savastano S (2011) Medical treatment of prolactinomas. Nat Rev Endocrinol 7(5):267–278
Colao A, Lombardi G, Annunziato L (2000) Cabergoline. Expert Opin Pharmacother 1(3):555–574
Colao A, Auriemma RS, Pivonello R (2016) The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Pituitary 19(2):210–221
Dagistanli FK, Ozkaya HM, Kucukyoruk B et al (2018) Preoperative somatostatin analogue treatment might trigger apoptosis and autophagy in tumor tissues of patients with acromegaly: a pilot study. Exp Clin Endocrinol Diabetes 126(3):168–175
Daido S, Yamamoto A, Fujiwara K et al (2005) Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 65(10):4368–4375
Dang CN, Trainer P (2007) Pharmacological management of Cushing’s syndrome: an update. Arq Bras Endocrinol Metabol 51(8):1339–1348
Ezzat S, Asa SL, Couldwell WT et al (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613–619
Farquhar MG (1969) Lysosome function in regulating secretion: disposal of secretory granules in cells of the anterior pituitary gland. In Lysosomes in Biol Pathol 2:462–482
Farquhar MG (1971) Processing of secretory products by cells of the anterior pituitary gland. Memoirs of the Soc Endocrinol 19:79–122
Farrell CJ, Nyquist GG, Farag AA et al (2016) Principles of pituitary surgery. Otolaryngol Clin North Am 49(1):95–106
Feelders R, Hofland L (2013) Medical treatment of cushing’s disease. J Clin Endocr Metab 98(2):425–438
Gadelha MR, Bronstein MD, Brue T et al (2014) Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. Lancet Diabetes Endocrinol 2(11):875–884
Geng X, Ma L, Li Z et al (2017) Bromocriptine induces autophagy-dependent cell death in pituitary adenomas. World Neurosurg 100:407–416
George SR, Kovacs K, Asa SL et al (1987) Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma. Clin Endocrinol (Oxf) 26(4):395–405
Greenman Y, Cooper O, Yaish I et al (2016) Treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists. Eur J Endocrinol 175(1):63–72
Han MW, Lee JC, Choi JY et al (2014) Autophagy inhibition can overcome radioresistance in breast cancer cells through suppression of TAK1 activation. Anticancer Res 34(3):1449–1455
Hombach-Klonisch S, Mehrpour M, Shojaei S et al (2018) Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response. Pharmacol Ther 184:13–41
Horvath E, Kovacs K, Killinger DW et al (1980) Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 98(3):617–638
Huang HY, Zhai W, Tang H et al (2018) Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas. Endocrine 62(2):464–469
Junn E, Mouradian MM (2001) Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem 78(2):374–383
Kanzawa T, Germano IM, Komata T et al (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11(4):448–457
Katayama M, Kawaguchi T, Berger MS et al (2007) DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 14(3):548–558
Katznelson L, Laws ER Jr, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951
Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Sci 290 (5497):1717–1721
Kovacs K, Horvath E, Ilse RG et al (1977) Spontaneous pituitary adenomas in aging rats. A light microscopic, immunocytological and fine structural study. Beitr Pathol 161(1):1–16
Kovacs K, Horvath E, Bayley TA et al (1978) Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. Am J Med 64(3):492–499
Kun Z, Yuling Y, Dongchun W et al (2016) HIF-1alpha inhibition sensitized pituitary adenoma cells to temozolomide by regulating Presenilin 1 expression and autophagy. Technol Cancer Res Treat 15(6):Np95–Np104
Kuriakose NR, Reifel CW, Bendayan M et al (1989) Prolactin crinophagy is induced in the estrogen-stimulated male rat pituitary. Histochemistry 92(6):499–503
Leng ZG, Lin SJ, Wu ZR et al (2017) Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death. Autophagy 13(8):1404–1419
Lim S, Shahinian H, Maya MM et al (2006) Temozolomide: a novel treatment for pituitary carcinoma. Lancet Oncol 7(6):518–520
Lin SJ, Leng ZG, Guo YH et al (2015) Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline. Oncotarget 6(36):39329–39341
Lin SJ, Wu ZR, Cao L et al (2017) Pituitary tumor suppression by combination of cabergoline and chloroquine. J Clin Endocrinol Metab 102(10):3692–3703
Liu C, He W, Jin M et al (2015a) Blockage of autophagy in C6 glioma cells enhanced radiosensitivity possibly by attenuating DNA-PK-dependent DSB due to limited Ku nuclear translocation and DNA binding. Curr Mol Med 15(7):663–673
Liu JK, Patel J, Eloy JA (2015b) The role of temozolomide in the treatment of aggressive pituitary tumors. J Clin Neurosci 22(6):923–929
Lomonaco SL, Finniss S, Xiang C et al (2009) The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer 125(3):717–722
Mancias JD, Kimmelman AC (2011) Targeting autophagy addiction in cancer. Oncotarget 2(12):1302–1306
Messerer M, De Battista JC, Raverot G et al (2011) Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 30(4):E11
Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol. https://doi.org/10.1007/s12022-017-9498-z
Moi VD, Bacsy E, Gaal G et al (1984) Lysosomal enzyme activities in hypo- and hypersecretory anterior pituitary cells. A combined immunocytochemical and enzyme cytochemical study. Histochemistry 81(1):79–85
Mooney MA, Simon ED, Little AS (2016) Advancing treatment of pituitary adenomas through targeted molecular therapies: the acromegaly and cushing disease paradigms. Front Surg 3:45
Paglin S, Yahalom J (2006) Pathways that regulate autophagy and their role in mediating tumor response to treatment. Autophagy 2(4):291–293
Palumbo S, Comincini S (2013) Autophagy and ionizing radiation in tumors: the “survive or not survive” dilemma. J Cell Physiol 228(1):1–8
Palumbo S, Pirtoli L, Tini P et al (2012) Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. J Cell Biochem 113(7):2308–2318
Poole MC, Mahesh VB, Costoff A (1981) Morphometric analysis of the autophagic and crinophagic lysosomal systems in mammotropes throughout the estrous cycle of the rat. Cell Tissue Res 220(1):131–137
Radl DB, Ferraris J, Boti V et al (2011) Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor. PLoS ONE 6(3):e18097
Raverot G, Burman P, McCormack A et al (2018) European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1–G24
Rubinsztein DC, Codogno P, Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11(9):709–730
Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306(5698):990–995
Sirek AM, Horvath E, Ezrin C et al (1976) Effect of starvation on pituitary growth hormone cells and blood growth hormone and prolactin levels in the rat. Nutr Metab 20(1):67–75
Smith RE, Farquhar MG (1966) Lysosome function in the regulation of the secretory process in cells of the anterior pituitary gland. J Cell Biol 31(2):319–347
Sotelo J, Briceno E, Lopez-Gonzalez MA (2006) Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144(5):337–343
Syro LV, Ortiz LD, Scheithauer BW et al (2011) Treatment of pituitary neoplasms with temozolomide: a review. Cancer 117(3):454–462
Tang C, Sun R, Wen G et al (2019) Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively. Cell Death Dis 10(5):335
Thorburn A, Morgan MJ (2015) Targeting autophagy in BRAF-mutant tumors. Cancer Discov 5(4):353–354
Torres S, Lorente M, Rodríguez-Fornés F et al (2011) A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther 10(1):90–103
Verhelst J, Abs R, Maiter D et al (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84(7):2518–2522
Wang AT, Mullan RJ, Lane MA et al (2012) Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev 1:33
Wang Y, Yin W, Zhu X (2014) Blocked autophagy enhances radiosensitivity of nasopharyngeal carcinoma cell line CNE-2 in vitro. Acta Otolaryngol 134(1):105–110
Weckman A, Di Ieva A, Rotondo F et al (2014) Autophagy in the endocrine glands. J Mol Endocrinol 52(2):R151–163
Weckman A, Rotondo F, Di Ieva A et al (2015) Autophagy in endocrine tumors. Endocr Relat Cancer 22(4):R205–218
Wu ZB, Yu CJ, Su ZP et al (2006) Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up. J Neurosurg 104(1):54–61
Wu ZB, Su ZP, Wu JS et al (2008) Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion. Pituitary 11(1):63–70
Wu Z, Cai L, Lu J et al (2018) MicroRNA-93 mediates cabergoline-resistance by targeting ATG7 in prolactinoma. J Endocrinol. https://doi.org/10.1530/JOE-18-0203
Xin Y, Jiang F, Yang C et al (2017) Role of autophagy in regulating the radiosensitivity of tumor cells. J Cancer Res Clin Oncol 143(11):2147–2157
Yamada S, Fukuhara N, Horiguchi K et al (2014) Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg 121(6):1462–1473
Zhang L, Hapon MB, Goyeneche AA et al (2016) Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors. Mol Oncol 10(7):1099–1117
Zhang D, Way JS, Zhang X et al (2019) Effect of everolimus in treatment of aggressive prolactin-secreting pituitary adenomas. J Clin Endocrinol Metabol 104(6):1929–1936
Zhuang W, Li B, Long L et al (2011) Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer 129(11):2720–2731
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Science Press and Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wu, Z., Gu, W. (2020). Autophagy and Pituitary Adenoma. In: Le, W. (eds) Autophagy: Biology and Diseases. Advances in Experimental Medicine and Biology, vol 1207. Springer, Singapore. https://doi.org/10.1007/978-981-15-4272-5_12
Download citation
DOI: https://doi.org/10.1007/978-981-15-4272-5_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-4271-8
Online ISBN: 978-981-15-4272-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)